Reducing hip fracture risk with risedronate in elderly women with established osteoporosis.

Clinical interventions in aging

Volumn 4, Issue , 2009, Pages 445-449

  Masud, Tahir ^a   McClung, Michael ^a   Geusens, Piet ^a  

^a NOTTINGHAM UNIVERSITY HOSPITALS NHS TRUST   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BONE DENSITY CONSERVATION AGENT; DRUG DERIVATIVE; ETIDRONIC ACID; RISEDRONIC ACID;

AGED; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; HIP FRACTURE; HUMAN; POSTMENOPAUSE OSTEOPOROSIS; RANDOMIZED CONTROLLED TRIAL; RISK REDUCTION; TREATMENT OUTCOME;

AGED; AGED, 80 AND OVER; BONE DENSITY CONSERVATION AGENTS; ETIDRONIC ACID; FEMALE; HIP FRACTURES; HUMANS; OSTEOPOROSIS, POSTMENOPAUSAL; RISK REDUCTION BEHAVIOR; TREATMENT OUTCOME;

MLCS; MLOWN;

EID: 77950495408     PISSN: None     EISSN: 11781998     Source Type: Journal    
DOI: 10.2147/cia.s8200     Document Type: Article

References (0)